We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Guidance on eSubmission of Biologics Lot Distribution Reports
FDA Finalizes Guidance on eSubmission of Biologics Lot Distribution Reports
Biologics makers should file their lot distribution reports using the same electronic messaging standard as is used for drug registration and labeling content of BLAs, FDA final guidance says.